Promethera Bsc
About
Promethera Biosciences is pioneering the development of cutting-edge cell-based therapies for the treatment of liver to reduce the need for transplantation
- Website
- Headquarters
- Industry
- Social
Org chart
View all (22)
John Tchelingerian
President & CEO
Bertrand Lellouche
Group CFO
David Brems
VP Finance
Houssam Zazgad
COO ad interim
Luc Otten
Chief Scientific Officer
Michihiro Maeda
GM Japan Branch
Nathalie Clerget
SVP Clinical Development & Regulatory Affairs
Thomas Van Loock
Global VP QA & QP
William Macias
CMO ad interm
Andreas Nuessler
Advisor
Anil Dhawan
Advisor
Charles L. Dimmler
Chairman of the Board
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.